Home / Resource Library / Outcomes of Richter syndrome in patients with chronic lymphocytic leukemia (CLL) treated with platinum or anthracycline based chemotherapy with or without a BTK inhibitor (BTKi)

Outcomes of Richter syndrome in patients with chronic lymphocytic leukemia (CLL) treated with platinum or anthracycline based chemotherapy with or without a BTK inhibitor (BTKi)

ASCO 2022

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

Outcomes of Richter syndrome in patients with chronic lymphocytic leukemia (CLL) treated with platinum or anthracycline based chemotherapy with or without a BTK inhibitor (BTKi)